Performance Equivalence and Validation of a Rapid Microbiological Method for Detection and Quantification of Yeast and Mold in an Antacid Oral Suspension

References

1. 1.↵
   1. Saghee M. R.,
   2. Sandle T.,
   3. Tidswell E. C.

   1. Denoya C. D.

   Alternative Microbiological Methods and New Pharmaceutical Microbiology Curriculum. In Microbiology and Sterility Assurance in Pharmaceuticals and Medical Devices, 1st ed.; Saghee M. R., Sandle T., Tidswell E. C., Eds.; Business Horizons Pharmaceutical Publishers: New Delhi, India, 2010; Chapter 20, pp 491–518.

   Google Scholar
2. 2.↵
   World Health Organization. WHO Technical Report Series No. 961: Annex 6: WHO Good Manufacturing Practices for Sterile Pharmaceutical Products. WHO: Geneva, 2011; pp 263.

   Google Scholar
3. 3.↵
   Council of Europe. Alternative Methods for Control of Microbiological Quality, Chapter 5.1.6. In European Pharmacopoeia (Ph. Eur.) 9th Edition, Council of Europe: Strasbourg, France, 2017; pp 532–543.

   Google Scholar
4. 4.↵
   British Pharmacopoeia Commission. Alternative Methods for Control of Microbiological Quality. In: British Pharmacopoeia; TSO: London, 2019; Vol. V, Supplementary Chapter IV–K, pp A800–A810.

   Google Scholar
5. 5.↵
   Ministry of Health Labour and Welfare of Japan, Rapid Microbial Methods. In The Japanese Pharmacopoeia, 17th Edition (English Version), MHLW: Tokyo, 2016; pp 2507–2509.

   Google Scholar
6. 6.↵
   1. Pereault M.,
   2. Alles S.,
   3. Caballero O.,
   4. Sarver R.,
   5. McDougal S.,
   6. Mozola M.,
   7. Rice J.

   Validation of the Soleris® Direct Yeast and Mold Method for Semiquantitative Determination of Yeast and Mold in a Variety of Foods. J. AOAC Int. 2014, 97 (4), 1084–1091.

   OpenUrlGoogle Scholar
7. 7.↵
   1. Foti D.,
   2. Romano L.,
   3. Alles S.,
   4. Mozola M. A.

   Validation of the Soleris® E. coli Method for Detection and Semi-Quantitative Determination of Escherichia coli in Foods. J. AOAC Int. 2012, 95 (3), 786–794.

   OpenUrlPubMedGoogle Scholar
8. 8.↵
   1. Alles S.,
   2. McDougal S.,
   3. Caballero O.,
   4. Mozola M.,
   5. Rice J.

   Validation of a Minor Modification to the Soleris® Direct Yeast and Mold Vial and Selective Supplement. J. AOAC Int. 2015, 98 (5), 1286–1289.

   OpenUrlGoogle Scholar
9. 9.↵
   1. Montei C.,
   2. McDougal S.,
   3. Mozola M.,
   4. Rice J.

   Semiquantitative Determination of Mesophilic, Aerobic Microorganisms in Cocoa Products Using the Soleris® NF-TVC Method. J. AOAC Int. 2014, 97 (1), 155–158.

   OpenUrlGoogle Scholar
10. 10.↵
    1. Henriques J.,
    2. Cardoso C.,
    3. Vitorino C.

    Rapid Microbiological Methods. They Are Rapid! Are They Fast? In Research Trends of Microbiology; MedDocs Publishers LLC., 2019.

    Google Scholar
11. 11.↵
    1. Miller M. J.

    The Implementation of Rapid Microbiological Methods. Eur. Pharm. Rev. 2010, (5).

    Google Scholar
12. 12.↵
    1. Miller M. J.

    Case Study of a New Growth-Based Rapid Microbiological Method (RMM) That Detects the Presence of Specific Organisms and Provides an Estimation of Viable Cell Count. Am. Pharm. Rev 2012, 15 (2), 18–25.

    OpenUrlGoogle Scholar
13. 13.↵
    1. Clark C. L.,
    2. Merritt A. M.,
    3. Burrow J. A.,
    4. Steible C. K.

    Effect of Aluminum Hydroxide/Magnesium Hydroxide Antacid and Bismuth Subsalicylate on Gastric pH in Horses. J. Am. Vet. Med. Assoc. 1996, 208 (10), 1687–1691.

    OpenUrlPubMedGoogle Scholar
14. 14.↵
    1. Hem S. L.,
    2. White J. L.,
    3. Buehler J. D.,
    4. Luber J. R.,
    5. Grim W. M.,
    6. Lipka E. A.

    Evaluation of Antacid Suspensions Containing Aluminum Hydroxide and Magnesium Hydroxide. Am. J. Hosp. Pharm. 1982, 39 (11), 1925–1930.

    OpenUrlAbstractGoogle Scholar
15. 15.↵
    1. El-Serag H. B.,
    2. Sweet S.,
    3. Winchester C. C.,
    4. Dent J.

    Update on the Epidemiology of Gastro-Oesophageal Reflux Disease: A Systematic Review. Gut 2014, 63 (6), 871–880.

    OpenUrlAbstract/FREE Full TextGoogle Scholar
16. 16.↵
    1. Eisen G.

    The Epidemiology of Gastroesophageal Reflux Disease: What We Know and What We Need to Know. Am. J. Gastroenterol. 2001, 96 (8 Suppl), 16–18.

    OpenUrlPubMedWeb of ScienceGoogle Scholar
17. 17.↵
    1. Sontag S. J.

    The Medical Management of Reflux Esophagitis. Role of Antacids and Acid Inhibition. Gastroenterol. Clin. North Am. 1990, 19 (3), 683–712.

    OpenUrlPubMedWeb of ScienceGoogle Scholar
18. 18.↵
    1. Mozola M.,
    2. Gray L. R.,
    3. Feldpausch J.,
    4. Alles S.,
    5. McDougal S.,
    6. Montei C.,
    7. Sarver R.,
    8. Steiner B.,
    9. Cooper C.,
    10. Rice J.

    Validation of the Soleris® NF-TVC Method for Determination of Total Viable Count in a Variety of Foods. J. AOAC Int. 2013, 96 (2), 399–403.

    OpenUrlGoogle Scholar
19. 19.↵
    U.S. Pharmacopeial Convention, General Chapter <1111> Microbiological Examination of Nonsterile Products: Acceptance Criteria for Pharmaceutical Preparation and Substances for Pharmaceutical Use. In USP 43–NF 38 2S, USP: Rockville, MD, 2020.

    Google Scholar
20. 20.↵
    U.S. Pharmacopeial Convention, General Chapter <61> Microbiological Examination of Nonsterile Products: Microbial Enumeration Tests. In USP 43–NF 38 2S, USP: Rockville, MD, 2020.

    Google Scholar
21. 21.↵
    1. Alles S.,
    2. Shrestha N.,
    3. Ellsworth A.,
    4. Rider A.,
    5. Foti D.,
    6. Knickerbocker J.,
    7. Mozola M.

    Validation of the Soleris Yeast and Mold Test for Semiquantitative Determination of Yeast and Mold in Selected Foods. J. AOAC Int. 2009, 92 (5), 1396–1415.

    OpenUrlPubMedGoogle Scholar
22. 22.↵
    1. Ritter A.

    Análisis Microbiológicos Rápidos: Evaluación de Diferentes Métodos y Sus Aplicaciones. Pharm. Technol. 2014, 1 (1), 4–7.

    OpenUrlGoogle Scholar
23. 23.↵
    1. Nemati M.,
    2. Hamidi A.,
    3. Maleki Dizaj S.,
    4. Javaherzadeh V.,
    5. Lotfipour F.

    An Overview on Novel Microbial Determination Methods in Pharmaceutical and Food Quality Control. Adv. Pharm. Bull. 2016, 6 (3), 301–308.

    OpenUrlGoogle Scholar
24. 24.↵
    U.S. Pharmacopeial Convention, General Chapter <1223> Validation of Alternative Microbiological Methods. In USP 43–NF 38 2S, USP: Rockville, MD, 2020.

    Google Scholar
25. 25.↵
    1. Limberg B. J.,
    2. Johnstone K.,
    3. Filloon T.,
    4. Catrenich C.

    Performance Equivalence and Validation of the Soleris Automated System for Quantitative Microbial Content Testing Using Pure Suspension Cultures. J. AOAC Int. 2016, 99 (5), 1331–1337.

    OpenUrlGoogle Scholar
26. 26.↵
    1. Easter M. C.

    1. Newby P. J.,
    2. Johnson B.

    Overview of Alternative Rapid Microbiological Methods. In Rapid Microbiological Methods in the Pharmaceutical Industry, Easter M. C., Ed.; CRC Press: Boca Raton, FL, 2003; pp 28–40.

    Google Scholar
27. 27.↵
    Parental Drug Association Inc. Technical Report No. 33: Evaluation, Validation and Implementation of Alternative and Rapid Microbial Methods; Bethesda, MD, 2013.

    Google Scholar
28. 28.↵
    U.S. Pharmacopeial Convention, General Chapter <1227>Validation of Microbial Recovery from Pharmacopeial Articles. In USP 43–NF 38 2S, USP: Rockville, MD, 2020.

    Google Scholar
29. 29.↵
    1. Matwiejczuk N.,
    2. Galicka A.,
    3. Brzóska M. M.

    Review of the Safety of Application of Cosmetic Products Containing Parabens. J. Appl. Toxicol. 2020, 40 (1), 176–210.

    OpenUrlGoogle Scholar
30. 30.↵
    Soleris Operator's Manual, Version 7.3; Neogen: Lansing, MI, 2014.

    Google Scholar
31. 31.↵
    1. McCormick P. J.,
    2. Schoene M. J.,
    3. Dehmler M. A.,
    4. Kaiser J. J.,
    5. Norton S. E.,
    6. Pizon A.,
    7. Fornalik M. A.

    Evaluation of a Rapid Microbiological Method with a Mixed Culture Biofilm Model. PDA J. Pharm. Sci. Technol. 2013, 67 (5), 512–532.

    OpenUrlAbstract/FREE Full TextGoogle Scholar